Authors
Latest:
Using CBT to Empower Black PatientsJudith S. Beck, PhD, and Janeé M. Steele, PhD, engage in a conversation about how clinicians from all backgrounds can address issues of race in session and also empower Black patients with a sense of personal pride in their identities.
Latest:
Supporting Ukrainian Mental Health“The acute and long-term psychological consequences of this tragedy will require large-scale aid.”
Latest:
Here's to a Psychedelic RevolutionResearch is underway to make psychedelics agents a treatment option for psychiatric disorders.
Latest:
Perspectives on Global Women’s Mental HealthThis diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.
Latest:
AMA President Addresses the State of Medicine“We didn’t pick this political fight, but we will stand up for our patients, for the policies of this House, and for our profession.”
Latest:
Breaking the Spell: Fighting Myths About COVID-19 VaccinationThe vaccine needs to be appropriately framed: as a benefit, not a risk.
Latest:
Media & Mental Health: The Need for More Credible InformationHas the media’s obsession with the COVID-19 pandemic put global mental health at risk?
Latest:
Winning the Battle: Reflections of a Psychiatrist Living With BPADOne professional psychiatrist shares his account of living with bipolar affective disorder.
Latest:
Zuranolone for the Treatment of Adults With Major Depressive DisorderThis randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.
Latest:
D-cycloserine for Anxiety Disorders: What Psychiatrists Need to KnowD-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.
Latest:
Mount Sinai Study Shows That Human Beliefs About Drugs Could Have Dose-Dependent Effects on the Brain"Our findings provide a mechanistic explanation for the well-known variations in individual responses to drugs and suggest that subjective beliefs could be a direct target for the treatment of substance use disorders," said Xiaosi Gu, PhD, senior author of the study.
Latest:
Shattered Self: Schizophrenia Suffering, Beyond Logic and ReasonHow can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?
Latest:
Surviving Vaccine Hesitancy TogetherWhat is the mindset of “anti-vaxxers,” and how can you connect with them as a clinician?
Latest:
Issues in Regulating DTxWe need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Latest:
Facilitating Collections From PatientsCollecting fees is essential, but it can be uncomfortable and even difficult. What strategies can you use to ease the burden?
Latest:
“Oh No, My Patient is a Physician!” Hurdles When Treating Physician-PatientsCaring for physician-patients can be a challenge…
Latest:
Racism, Policing, and COVID-19 Disparities: We Need Action!This moment in history cannot be lost. When you ask us if we are okay, be prepared to hear us say we are not . . . and never have been. Then be prepared to do more.
Latest:
Special Considerations for SGM Youth OnlineOnline environments have revolutionized the lives of young SGM individuals, but also created unforeseen issues...
Latest:
Organized Psychiatry Provides Strength and Value to Mental Health Professionals"Organized medicine and specialty organizations are key pillars of support for individual physicians that provide opportunities to advocate for more funding and resources for the medical system and education."
Latest:
A New Conference Series: Improving Black Youth Mental HealthAre you ready to discuss the Black youth crisis and the need for dynamic conversations?
Latest:
Augmentation Strategies for Treatment-Resistant DepressionGiven that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.
Latest:
Abstinence vs Drinking in ModerationWhich is the best recommendation for the treatment of alcohol use disorder?
Latest:
The Science, Ethics, and Art of Disclosing a Dementia DiagnosisHow can you communicate the diagnosis in a way that relieves suffering and helps patients and their caregivers prepare for the future?
Latest:
Mental Health Disparities Among Black Americans During the COVID-19 PandemicThe COVID-19 pandemic has disproportionately affected people of color due to legal, social, and economic inequities.
Latest:
Confidentiality Dilemmas: HIPAA, Friend or Foe?Clinicians can ensure high-quality care by remaining informed about legal and ethical considerations in navigating patient privacy dilemmas.
Latest:
Phase 3 Trials Examine Gantenerumab for Early Alzheimer DiseaseTwo phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.
Latest:
Digital Health as an Enabler for Patient-Centric, Outcome-Based CareConsidering challenges and opportunities in digital health solutions for mental health care.
Latest:
What Is Complex Posttraumatic Stress Disorder and How Does It Relate to Borderline Personality Disorder?Whether a patient has a diagnosis of cPTSD, BPD, or some combination of both, treatment should be considered multifaceted and overlapping. Learn more in this Special Report article.
